Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  recombinant macrophage colony-stimulating factor
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-13 of 13 for your search:
Start Over
Phase I/II Evaluation of Macrophage Colony Stimulating Factor in Patients with Advanced Cancer (Summary Last Modified 12/89)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: NCI-89-C-167A, NCI-T89-0082N, T89-0082
Phase II Trial of Murine Monoclonal Antibody D6.12 plus M-CSF in Patients with Advanced Colorectal or Gastric Carcinoma (Summary Last Modified 12/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: UAC-2129, NCI-B92-0003, B92-0003
Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CO08802, NCT00849121
Phase IA/IB Study of rM-CSF in Patients with Cancer (Summary Last Modified 08/91)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: CCF-RPC-3272A, NCI-B90-0001, B90-0001
Phase I Study of M-CSF in Patients with Myelodysplastic Syndrome (Summary Last Modified 06/91)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: AECM-9006164, NCI-V90-0128
Phase I Study of Recombinant Human M-CSF in Patients with Acute Myelogenous Leukemia (Summary Last Modified 11/90)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: AECM-9006166, NCI-V90-0129
Phase I Study of M-CSF in Pediatric Patients with Refractory Neuroblastoma, Osteosarcoma, and Other GD2- and GD3-Positive Tumors (Summary Last Modified 04/91)
Phase: Phase I
Type: Treatment
Status: Completed
Age: child
Sponsor:
Protocol IDs: MSKCC-90114, NCI-V91-0010
Phase I Study of M-CSF/IFN-G in Patients with Advanced Malignancies (Summary Last Modified 09/92)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FCCC-90073, NCI-T90-0157D, T90-0157
Phase I Study of MOAB R24/M-CSF in Patients with Advanced Melanoma (Summary Last Modified 06/92)
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: MSKCC-91017, NCI-B90-0015, B90-0015
Phase I Study of M-CSF Given by Continuous Infusion in Patients with Refractory Metastatic Cancer (Summary Last Modified 06/97)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-91-C-123C, NCI-T91-0143N, T91-0143
Phase Ib Study of MOAB R24 Combined with M-CSF or GM-CSF in Patients with Metastatic Melanoma (Summary Last Modified 09/91)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to physiologic 70
Sponsor:
Protocol IDs: UCLA-9101040, NCI-B91-0001, B91-0001
Start Over